
Primary care spirometry is a uniquely valuable tool in the evaluation of patients with respiratory symptoms, allowing the general practitioner to diagnose or exclude chronic obstructive pulmonary disease (COPD), sometimes to confirm asthma, to determine the efficacy of asthma treatment and to correctly stage patients with COPD. The use of spirometry for case finding in asymptomatic COPD patients might become an option, once early intervention studies have shown it to be beneficial in these patients.The diagnosis of airway obstruction requires accurate and reproducible spirometric measurements, which should comply with the American Thoracic Society (ATS)/European Respiratory Society (ERS) guidelines. Low acceptability of spirometric manoeuvres has been reported in primary care practices. This may hamper the validity of the results and affect clinical decision making. Training and refresher courses may produce and maintain good-quality testing, promote the use of spirometric results in clinical practice and enhance the quality of interpretation.Softening the stringent ATS/ERS criteria could enhance the acceptability rates of spirometry when used in a general practice. However, the implications of potential simplifications on the quality of the data and clinical decision making remain to be investigated.Hand-held office spirometers have been developed in recent years, with a global quality and user-friendliness that makes them acceptable for use in general practices. The precision of the forced vital capacity measurements could be improved in some of the available models.
Lung Diseases, Pulmonary function, Flow-volume loop, Heart Diseases, Quality Assurance, Health Care, Vital Capacity, heart failure, 610, clinical decision making, bronchitis, Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volume, medical rese Airways obstruction, Pulmonary Medicine, Humans, human, American Thoracic Society/European Respiratory Society criteria, Forced expiratory volume in one second, airway obstruction, Clinical Trials as Topic, Primary Health Care, Chronic obstructive pulmonary disease, Equipment Design, asthma, dyspnea, Keywords: antiinflammatory agent, forced expiratory volume, clinical practice, early intervention, Spirometry, bronchodilating agent, chronic obstructive lung disease, Software
Lung Diseases, Pulmonary function, Flow-volume loop, Heart Diseases, Quality Assurance, Health Care, Vital Capacity, heart failure, 610, clinical decision making, bronchitis, Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volume, medical rese Airways obstruction, Pulmonary Medicine, Humans, human, American Thoracic Society/European Respiratory Society criteria, Forced expiratory volume in one second, airway obstruction, Clinical Trials as Topic, Primary Health Care, Chronic obstructive pulmonary disease, Equipment Design, asthma, dyspnea, Keywords: antiinflammatory agent, forced expiratory volume, clinical practice, early intervention, Spirometry, bronchodilating agent, chronic obstructive lung disease, Software
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 123 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
